Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001701523-17-000001
Filing Date
2017-08-18
Accepted
2017-08-18 15:39:28
Documents
1
Effectiveness Date
2017-08-18
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6296
  Complete submission text file 0001701523-17-000001.txt   7306
Mailing Address 430 NASSAU ST PRINCETON NJ 08540
Business Address 430 NASSAU ST PRINCETON NJ 08540 6094971282
Illuminare Biotechnologies Inc (Filer) CIK: 0001701523 (see all company filings)

EIN.: 812564534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-293139 | Film No.: 171041057